Gender bleeding rates by risk categories
| Male, n (%) | Female, n (%) | OR (CI) for gender | p Value | |
|---|---|---|---|---|
| 2B3A inhibitors (n=16 739) | 344 (3.0) | 373 (7.0) | 2.4 (2.1 to 2.8) | 0.000 |
| STEMI (n=5194) | 193 (5.2) | 165 (11.1) | 2.2 (1.8 to 2.8) | 0.000 |
| NSTEMI (n=7152) | 113 (2.4) | 146 (6.2) | 2.7 (2.1 to 3.5) | 0.000 |
| Stable angina (n=4386) | 38 (1.3) | 62 (4.2) | 3.3 (2.2 to 5.0) | 0.000 |
| No 2B3A inhibitors (n=38 992) | 204 (0.8) | 311 (2.4) | 3.0 (2.5 to 3.6) | 0.000 |
| STEMI (n=2474) | 48 (2.9) | 40 (5.0) | 1.7 (1.2 to 2.7) | 0.01 |
| NSTEMI (n=19 320) | 92 (0.7) | 173 (2.6) | 3.5 (2.8 to 4.6) | 0.000 |
| Stable Angina (n=17 178) | 64 (0.6) | 98 (1.7) | 3.2 (2.3 to 4.4) | 0.000 |
NSTEMI, non-ST segment elevation myocardial infarction; STEMI, ST segment elevation myocardial infarction.